STAT5A and breast carcinoma: On the one hand, STAT5a promotes transformation of mammary epithelial cells and survival of breast cancer cells (35, 36); on the other hand, STAT5a is associated with a relatively good prognosis for patient survival since it promotes mammary epithelial cell differentiation (37–40).